Via a unique regulatory route in the UK, scientists found that a gene therapy restored vision in young kids with a very rare and severe retinal dystrophy.
The team at DropGenie uses digital microfluidics to perform gene editing screens on small numbers of patient cells, accelerating the discovery of new drugs.
By watching brain organoids develop, researchers observed surprising abnormalities caused by mutations in a gene related to early-onset Alzheimer’s disease.
Explore how a needs-driven approach to electronic laboratory notebook selection can improve data integrity, reproducibility, and scientific continuity.